114 related articles for article (PubMed ID: 34083297)
1. A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck.
Rades D; Staackmann C; Ribbat-Idel J; Perner S; Idel C; Bruchhage KL; Hakim SG; Schild SE
Anticancer Res; 2021 Jun; 41(6):3055-3058. PubMed ID: 34083297
[TBL] [Abstract][Full Text] [Related]
2. Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival.
Staackmann C; Ribbat-Idel J; Perner S; Idel C; Bruchhage KL; Hakim SG; Schild SE; Rades D
Anticancer Res; 2021 Jun; 41(6):3205-3210. PubMed ID: 34083316
[TBL] [Abstract][Full Text] [Related]
3. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
Rades D; Käsmann L; Schild SE; Janssen S
Clin Lung Cancer; 2016 Nov; 17(6):558-562. PubMed ID: 27341791
[TBL] [Abstract][Full Text] [Related]
4. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
[TBL] [Abstract][Full Text] [Related]
5. "Christie Regimen" palliative radiotherapy in advanced head-and-neck cancer: A single-center experience.
Srivastava A; Adhikari N; Sonkar DR; Singh K; Rathi AK
J Cancer Res Ther; 2021; 17(1):88-93. PubMed ID: 33723137
[TBL] [Abstract][Full Text] [Related]
6. Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review.
Desideri I; Becherini C; Belgioia L; Merlotti A; Ciccone LP; Franzese C; Loi M; De Felice F; Mazzola R; Caini S; Livi L; Bonomo P
Oral Oncol; 2021 Aug; 119():105355. PubMed ID: 34044315
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
[TBL] [Abstract][Full Text] [Related]
8. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
[TBL] [Abstract][Full Text] [Related]
9. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
11. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers.
Murthy V; Kumar DP; Budrukkar A; Gupta T; Ghosh-Laskar S; Agarwal J
Indian J Cancer; 2016; 53(1):138-41. PubMed ID: 27146764
[TBL] [Abstract][Full Text] [Related]
12. End stage palliative care of head and neck cancer: a case study.
Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
[TBL] [Abstract][Full Text] [Related]
13. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
Hamilton SN; Tran E; Berthelet E; Wu J; Olson R
Head Neck; 2018 Nov; 40(11):2432-2440. PubMed ID: 30295975
[TBL] [Abstract][Full Text] [Related]
14. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N;
Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182
[TBL] [Abstract][Full Text] [Related]
15. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
16. Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States.
Aggarwal H; Punekar RS; Li L; Carter GC; Walker MS
Health Qual Life Outcomes; 2020 Jun; 18(1):195. PubMed ID: 32571349
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care.
Kishino T; Mori T; Miyashita T; Ouchi Y; Samukawa Y; Fukumura T; Takahashi S; Monden N; Akisada N; Hayashi Y; Nakamura M; Hoshikawa H
Ear Nose Throat J; 2023 Jun; 102(6):379-384. PubMed ID: 33765857
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.
Al-Mamgani A; Kessels R; Verhoef CG; Navran A; Hamming-Vrieze O; Kaanders JHAM; Steenbakkers RJHM; Tans L; Hoebers F; Ong F; van Werkhoven E; Langendijk JA
Radiother Oncol; 2020 Aug; 149():181-188. PubMed ID: 32417345
[TBL] [Abstract][Full Text] [Related]
19. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
[TBL] [Abstract][Full Text] [Related]
20. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Maguire PD; Neal CR; Hardy SM; Schreiber AM
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]